Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

6 results
Display

Development of Clevudine Resistance after Switching from Lamivudine in a Patient with Chronic Hepatitis B

Koh KH, Kang CJ, Kim DH, Choi YW, Kim MJ, Cheong JY, Cho SW

  • KMID: 783106
  • Korean J Gastroenterol.
  • 2008 Nov;52(5):325-328.
Clevudine is a nucleoside analog of the unnatural beta-L configuration which has potent antiviral activity against hepatitis B virus (HBV). Clevudine is expected to have similar pattern of resistance profile...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Antiviral-Resistant Chronic Hepatitis B Virus Infection

Yim HJ

  • KMID: 1767539
  • Korean J Gastroenterol.
  • 2008 Jun;51(6):346-359.
Substantial progress has been made in the treatment of chronic hepatitis B during the past decade. Nucleos(t)ide analogues are now widely used due to their convenience, less side effects, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

Chae HB, Kim MJ, Seo EG, Choi YH, Lee HS, Han JH, Yoon SM, Park SM, Youn SJ

BACKGROUND/AIMS: Newly developed and potent antiviral agents suffer from the problem of drug resistance. Multidrug resistance is a major impediment in the treatment of patients with chronic hepatitis B (CHB)....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea

Lee AJ, Lee CH, Jeon CH

BACKGROUND: Most mutations in the reverse transcriptase (RT) gene of the hepatitis B virus (HBV) are related to resistance to antiviral agents. Cross-sectional studies on the mutations of this gene...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Antiviral Resistance in Chronic Hepatitis B

Lim YS

The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Multidrug-Resistant Human Immunodeficiency Virus Infection Treated with Atazanavir and Lopinavir/Ritonavir Combination Therapy

Choi H, Jeong SJ, Lee HS, Chin BS, Choi SH, Han SH, Kim MS, Kim CO, Choi JY, Song YG, Kim JM

The combination of atazanavir (ATV) and lopinavir/ritonavir (LPV/RTV) with nucleoside reverse transcriptase inhibitors (NRTI) has been used as a salvage regimen for human immunodeficiency virus (HIV)-positive patients. In this paper,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr